ArticleNeuroradiology2026
Differentiating medulloblastoma and pilocytic astrocytoma in children based on multimodal MRI radiomics model.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeMedulloblastoma (MB) and pilocytic astrocytoma (PA) are common in pediatric brain tumors and difficult to distinguish. To establish and evaluate a radiomics model based on multimodal MRI to distinguish medulloblastoma from pilocytic astrocytoma.
methodsRetrospective collection of magnetic resonance images from 113 patients with MB and 74 patients with PA. Radiomics analysis was performed on Dynamic Contrast-Enhanced T1 weighted imaging (DCE-T1WI), T2 weighted imaging (T2WI), and Apparent diffusion coefficient (ADC) images, respectively. A multimodal MRI combined radiomics model incorporating DCE-T1WI, T2WI, and ADC sequence features was developed by extraction of valuable features, and the radiomics nomogram was generated to evaluate its diagnostic capability. The DeLong test was used to compare the diagnostic performance of DCE-T1WI, T2WI, ADC single sequence model, and multimodal MRI radiomics model.
resultsThe combined model showed the highest performance among all models, with an area under the curve (AUC) of 0.999 on the primary cohort and maintained an AUC of 0.994 during the validation cohort. For the single-sequence model, the ADC sequence model performs better in the primary cohort, with an AUC of 0.996; the T2WI sequence model slightly outperforms in validation cohort, with an AUC of 0.985. The DCE-T1WI sequence model performed slightly worse than ADC and T2WI in the validation cohort, with an AUC of 0.951. Overall, the combined model performed best in the differential diagnosis of MB and PA.
conclusionMultimodal MRI-based radiomics analysis is effective in differentiating MB from PA and radiomics imaging may have important clinical significance in the preoperative detection of posterior fossa brain tumors in children.
Indexed as
Identifiers
41793451What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.